Evidence map›Paper›PMID 34856996›Full record

ArticleJournal of nanobiotechnology2021

Precision 3D printed meniscus scaffolds to facilitate hMSCs proliferation and chondrogenic differentiation for tissue regeneration.

Xingyu Deng, Xiabin Chen, Fang Geng, Xin Tang, Zhenzhen Li, Jie Zhang, Yikai Wang, Fangqian Wang, Na Zheng, Peng Wang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Xingyu Deng *School of Pharmacy, Hangzhou Normal University, Hangzhou, 311121, Zhejiang, China.
Xiabin Chen *School of Pharmacy, Hangzhou Normal University, Hangzhou, 311121, Zhejiang, China.
Fang Geng *Medtronic Technology Center, Shanghai, 201114, China.
Xin TangMedtronic Technology Center, Shanghai, 201114, China.
Zhenzhen LiSchool of Pharmacy, Hangzhou Normal University, Hangzhou, 311121, Zhejiang, China.
Jie ZhangSchool of Pharmacy, Hangzhou Normal University, Hangzhou, 311121, Zhejiang, China.
Yikai WangDepartment of Orthopaedics, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China.
Fangqian WangDepartment of Orthopaedics, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China.
Na ZhengState Key Laboratory of Chemical Engineering, School of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310027, China.
Peng WangThe State Key Laboratory of Translational Medicine and Innovative Drug Development, Nanjing, 210042, China.
Xiaohua YuDepartment of Orthopaedics, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China. xiaohua.yu@zju.edu.cn.
Shurong HouSchool of Pharmacy, Hangzhou Normal University, Hangzhou, 311121, Zhejiang, China. houshurong@hznu.edu.cn.
Wei ZhangMedtronic Technology Center, Shanghai, 201114, China. wei.zhang2@medtronic.com.
Hangzhou Normal University · CNMedtronic (China) · CNSecond Affiliated Hospital of Zhejiang University · CNZhejiang Provincial People's Hospital · CNZhejiang University · CN

Funding

Shanghai Pujiang Program of China 18PJ1430500
6 · The paper itself

Abstract

backgroundThe poor regenerative capability and structural complexity make the reconstruction of meniscus particularly challenging in clinic. 3D printing of polymer scaffolds holds the promise of precisely constructing complex tissue architecture, however the resultant scaffolds usually lack of sufficient bioactivity to effectively generate new tissue.

resultsHerein, 3D printing-based strategy via the cryo-printing technology was employed to fabricate customized polyurethane (PU) porous scaffolds that mimic native meniscus. In order to enhance scaffold bioactivity for human mesenchymal stem cells (hMSCs) culture, scaffold surface modification through the physical absorption of collagen I and fibronectin (FN) were investigated by cell live/dead staining and cell viability assays. The results indicated that coating with fibronectin outperformed coating with collagen I in promoting multiple-aspect stem cell functions, and fibronectin favors long-term culture required for chondrogenesis on scaffolds. In situ chondrogenic differentiation of hMSCs resulted in a time-dependent upregulation of SOX9 and extracellular matrix (ECM) assessed by qRT-PCR analysis, and enhanced deposition of collagen II and aggrecan confirmed by immunostaining and western blot analysis. Gene expression data also revealed 3D porous scaffolds coupled with surface functionalization greatly facilitated chondrogenesis of hMSCs. In addition, the subcutaneous implantation of 3D porous PU scaffolds on SD rats did not induce local inflammation and integrated well with surrounding tissues, suggesting good in vivo biocompatibility.

conclusionsOverall, this study presents an approach to fabricate biocompatible meniscus constructs that not only recapitulate the architecture and mechanical property of native meniscus, but also have desired bioactivity for hMSCs culture and cartilage regeneration. The generated 3D meniscus-mimicking scaffolds incorporated with hMSCs offer great promise in tissue engineering strategies for meniscus regeneration.

Indexed as

Printing, Three-DimensionalAnimalsCell DifferentiationCell ProliferationCells, CulturedChondrocytesChondrogenesisHumansMeniscusMesenchymal Stem CellsRatsRats, Sprague-DawleyRegenerationTissue EngineeringTissue ScaffoldsChondrogenic differentiationMeniscusScaffoldTissue engineering

Identifiers

PMID34856996
PMCPMC8641190
OpenAlexW3217701112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.